Distal femoral bone mineral density after Richards type II patellofemoral arthroplasty for isolated patellofemoral osteoarthritis: a 1-year follow-up study

Recruiting

• Conditions: disuse osteoporosis; periprosthetic bone resorption; 10023213; 10005944

• Registration Number: NL-OMON30609
• Lead Sponsor: Deventer Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Not applicable

Exclusion Criteria

Patients with rheumatic, renal, hepatic or gastrointestinal disease, and patients using medication that interferes with mineral metabolism (i.e. treatment for osteoporosis or long-term steroid therapy).
Previous total knee arthroplasty or patellofemoral arthroplasty of the contralateral knee.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>BMD (g/cm2) of the periprosthetic distal femur and contralateral (non-operated)<br /><br>knee before patellofemoral arthroplasty, directly after, and 12 months after<br /><br>arthroplasty.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>